Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane

Pharmazie

Volumn 66, Issue 8, 2011, Pages 594-599

  Singh, K H ^a   Shinde, Ujwala A ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; CHITOSAN; CHITOSAN NANOPARTICLE; EYE DROPS; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; PLACEBO; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EXCIPIENT; IRRITANT AGENT; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; EYE INJURY; GELATION; IN VITRO STUDY; INFRARED RADIATION; NONHUMAN; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; RABBIT; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; ELECTROCHEMISTRY; EYE; FREEZE DRYING; INFRARED SPECTROSCOPY; INTRAOCULAR PRESSURE; MEMBRANE; METABOLISM; SOLUBILITY;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; EXCIPIENTS; EYE; FREEZE DRYING; INTRAOCULAR PRESSURE; IRRITANTS; MEMBRANES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; QUINOXALINES; RABBITS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 80053321269     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0349     Document Type: Article

References (21)

1. Alonso MJ, Sánchez A (2003) The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 55: 1451-1463. (Pubitemid 37441350)
2. Annick L (2005) The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliver Rev 57: 1595-1639.
3. ASTM Standard D (1985) Zeta Potential of Colloids in Water and Waste Water. 4187-82.
4. Ballantyne B (1993) Ophthalmic Toxicology. In: Ballantyne B, Mars T, Turner P (ed.) General And Applied Toxicology. 1st ed., Lancaster, pp. 504-519.
5. Banning D, Dettmar PW, Jolliffe IG, Hampson FC, Onsoyen EJ, Field PF, Craig D, Quinell M, Kristensen AH. (2007) US Patent No. 6395307.
6. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ (1997) Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63: 125-132. (Pubitemid 127613982)
7. Chuanyun D, Bochu W, Hongwei Z (2005) Microencapsulation peptide and protein drugs delivery system. Colloid Surface B 41: 117-120.
8. De TK, Bergey EJ, Chung SJ, Rodman DJ, Bharali DJ, Prasad PN (2004) Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea. J Microencapsul 21: 841-855. http://www.pssnicomp. com/zetatheory.htm. (Pubitemid 40109549)
9. Kirk RW (2001) Draize test. Surv Ophthalmol 45: 493-515.
10. nd ed., New York, p. 437-466.
11. Macha S, Hughes PM, Mitra AK (2003) Overview of Ocular Drug Delivery. In: Ashim K Mitra (ed.) Ophthalmic Drug Delivery Systems. 2nd ed., New York, p 1-11.
12. Motwani SK, Chopra S, Talegaonkar S, Kohli K, Ahmad F J, Khar R K (2008) Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterization. Eur J Pharm Biopharm 68: 513-525. (Pubitemid 351318222)
13. Nagarwal RC, ShriKant, Singh PN, Maiti P, Pandit JK (2009) Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Release 136: 2-13.
14. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M (2008) Chitosan naoparticles loaded with dorzolamide and pramipexole. Carbohyd Polym 73: 44-54.
15. Rose J, Thill A, Brant J (2007) Method for Structural and Chemical Characterization of Nanomaterials. In: Wiesner MR, Bottero J (ed.), Environmental Nanotechnology, 1st ed., New York, p. 144.
16. Sahoo S. K, Krishnakumar S, Dilnawaz F (2008) Nanotechnology in ocular drug delivery. Drug Discov Today 13: 144-151.
17. Schultz B, Vogel WH (2002) Ophthalmologic activity. In: HG Vogel (ed.) Drug Discovery and Evaluation: Pharmacological Assays. 2nd ed., New York: 1295-1297.
18. Soltau JB, Zimmerman TJ (2002) Changing Paradigms in the Medical Treatment of Glaucoma. Surv Ophthalmol. 47: S2-S5. (Pubitemid 35232214)
19. Vauthier C, Bouhemal K (2009) Methods for the Preparation and Manufacture of Polymeric Nanoparticles. Pharm Res 26: 1025-1058.
20. Yaowalak B, Ampol M, Müller BW (2006) Chitosan drug binding by ionic interaction. Eur J Pharm Biopharm. 62: 267-274.
21. Yasmin S, R Jain, M Aqil, Asgar A (2006) Review of ocular drug delivery. Curr Drug Deliv 3: 207-217. (Pubitemid 43725018)